Nano-X Imaging (NNOX) director purchases 33,000 shares at $0.9000
Rhea-AI Filing Summary
Nano-X Imaging Ltd. director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026 at $0.9000 per share in an open-market or private transaction. He also reports existing stock options over 12,505, 50,000 and 10,000 shares at exercise prices of $64.6100, $17.6300 and $11.5200, plus 794 ordinary shares held indirectly through I.B.L. Business Consulting Ltd. Additional ordinary shares are reported as underlying restricted share units granted December 10, 2025 that vest in twelve equal monthly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 33,000 shares
Net Buy
6 txns
Insider
Kainan Noga
Role
Director
Bought
33,000 shs ($30K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares | 33,000 | $0.90 | $30K |
| holding | Stock Option (right to buy ordinary shares) F1, F3 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F1, F4 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F1, F5 | -- | -- | -- |
| holding | Ordinary Shares F1 | -- | -- | -- |
| holding | Ordinary Shares F1, F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 58,336 shares (Direct);
Stock Option (right to buy ordinary shares) — 72,505 shares (Direct);
Ordinary Shares — 794 shares (Indirect, By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person)
Footnotes (5)
- F1. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F2. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.
- F4. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).
Key Figures
Shares purchased: 33,000 shares
Purchase price: $0.9000 per share
Option exercise price: $64.6100
+3 more
6 metrics
Shares purchased
33,000 shares
Ordinary shares bought by director on July 28, 2026
Purchase price
$0.9000 per share
Price for 33,000 ordinary shares acquired
Option exercise price
$64.6100
Exercise price for options over 12,505 ordinary shares expiring February 9, 2031
Option exercise price
$17.6300
Exercise price for options over 50,000 ordinary shares expiring December 28, 2032
Option exercise price
$11.5200
Exercise price for options over 10,000 ordinary shares expiring December 31, 2033
Indirectly held shares
794 shares
Ordinary shares held via I.B.L. Business Consulting Ltd.
Key Terms
Stock Option (right to buy ordinary shares), restricted share units, fully vested and exercisable, indirect ownership
4 terms
fully vested and exercisable financial
"Options were granted and are fully vested and exercisable as of the date of this report"
indirect ownership financial
"Ordinary shares held indirectly by I.B.L. Business Consulting Ltd, wholly owned by the reporting person"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options in Nano-X Imaging (NNOX) does Kainan Noga report holding?
He reports stock options over 12,505 shares at $64.6100 expiring February 9, 2031, 50,000 shares at $17.6300 expiring December 28, 2032, and 10,000 shares at $11.5200 expiring December 31, 2033, all referencing ordinary shares as the underlying security.